Open access
Aug 2026
VEZT promotes pancreatic cancer progression by stabilizing SLC25A24 and preserving mitochondrial function
Background Pancreatic cancer (PC) is a highly aggressive malignancy with an unclear pathogenesis, limited therapeutic options, and poor prognosis. Vezatin (VEZT), an adherens junction transmembrane protein, has been implicated in the development and progression of several malignancies, including gastric cancer. However...
Le-Tian Chen, Zi-Han Yan, Zhi-Hao Fang et al.
· Frontiers in Immunology · 0 citations